Ciphergen Biosystems (MM) News - CIPH

Vermillion Completes Name Change From Ciphergen Biosystems

-- Stock to Trade Today Under New Nasdaq Symbol: VRML -- FREMONT, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Vermillion, Inc. today announced...

Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock

- Company Conference Call Originally Scheduled for 9:00 a.m. Eastern Time Today to Be Rescheduled After Private Placement Closes - FREMONT...

Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

FREMONT, Calif., Aug. 17 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) announced that on August 15, 2007 it received a...

Ciphergen Reports Second Quarter 2007 Financial Results and Business Progress

Ciphergen to Host Conference Call on Friday, August 24 at 9:00 a.m. Eastern FREMONT, Calif., Aug. 13 /PRNewswire-FirstCall/ -- Ciphergen...

Ciphergen Biosystems Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry Patent

Bio-Rad Laboratories to Pay $2 Million Upon Issuance of Patent Reexamination Certificate FREMONT, Calif., July 11 /PRNewswire-FirstCall/...

Ciphergen Biosystems Licenses More Than 25 Patents From Health Discovery Corporation

--Settles Patent Suit-- FREMONT, Calif., July 10 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) today announced that it had...

Ciphergen Biosystems Announces Results of Annual Meeting

FREMONT, Calif., July 6 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) announced today that at its annual meeting held on...

Ciphergen Biosystems Announces Issuance of European Patent Covering a Method for Aiding Bladder Cancer Diagnosis

FREMONT, Calif., May 30 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) today announced that the European Patent Office (EPO...

Ciphergen Reports First Quarter 2007 Financial Results and Business Progress

- Conference Call Today at 11 a.m. Eastern Time - FREMONT, Calif., May 16 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH...

Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing

FREMONT, Calif., May 15 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH) today announced the appointment of Steve Lundy as...

Ciphergen to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007

FREMONT, Calif., May 14 /PRNewswire-FirstCall/ -- Ciphergen Biosystems, Inc. (NASDAQ:CIPH), will announce first quarter 2007 financial results...

Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco

FREMONT, Calif., May 8 /PRNewswire-FirstCall/ -- Ciphergen (NASDAQ:CIPH) announced today that it will webcast its presentation at the Rodman...

Ciphergen Biosystems Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer

Data Presented at American Association for Cancer Research Annual Meeting FREMONT, Calif., April 16 /PRNewswire-FirstCall/ -- Ciphergen...

Ciphergen Biosystems Announces Presentation at Upcoming American Association for Cancer Research Annual Meeting

FREMONT, Calif., April 11 /PRNewswire-FirstCall/ -- Ciphergen Biosystems (NASDAQ:CIPH) today announced that the company and collaborators from...

Ciphergen Biosystems' Auditors Expressed Going-Concern Qualification

FREMONT, Calif., April 9 /PRNewswire-FirstCall/ -- Ciphergen Biosystems (NASDAQ:CIPH) announced today that in its 2006 financial statements...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ciphergen Biosystems (MM) (CIPH)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CIPH News

Vermillion Completes Name Change From Ciphergen Biosystems

Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock

Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Ciphergen Reports Second Quarter 2007 Financial Results and Business Progress

Ciphergen Biosystems Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry Patent

Ciphergen Biosystems Licenses More Than 25 Patents From Health Discovery Corporation

Ciphergen Biosystems Announces Results of Annual Meeting

Ciphergen Biosystems Announces Issuance of European Patent Covering a Method for Aiding Bladder Cancer Diagnosis

Ciphergen Reports First Quarter 2007 Financial Results and Business Progress

Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing

Ciphergen to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007

Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco

Ciphergen Biosystems Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer

Ciphergen Biosystems Announces Presentation at Upcoming American Association for Cancer Research Annual Meeting

Ciphergen Biosystems' Auditors Expressed Going-Concern Qualification

CIPH Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Ciphergen Biosystems (MM) (CIPH) News

Ciphergen Biosystems (MM) (CIPH)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

CIPH News

Vermillion Completes Name Change From Ciphergen Biosystems

Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock

Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market

Ciphergen Reports Second Quarter 2007 Financial Results and Business Progress

Ciphergen Biosystems Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry Patent

Ciphergen Biosystems Licenses More Than 25 Patents From Health Discovery Corporation

Ciphergen Biosystems Announces Results of Annual Meeting

Ciphergen Biosystems Announces Issuance of European Patent Covering a Method for Aiding Bladder Cancer Diagnosis

Ciphergen Reports First Quarter 2007 Financial Results and Business Progress

Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing

Ciphergen to Announce Q1 2007 Financial Results and Host Conference Call on Wednesday, May 16, 2007

Ciphergen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference, Monaco

Ciphergen Biosystems Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer

Ciphergen Biosystems Announces Presentation at Upcoming American Association for Cancer Research Annual Meeting

Ciphergen Biosystems' Auditors Expressed Going-Concern Qualification

CIPH Discussion

Your Recent History